How do we evaluate a stem cell journal? There is no doubt about it. The stem cell field has captured the imagination of people around the world of all occupations. Scientists themselves are captivated by stem cells. The number of articles on stem cells and the number of journals focused on stem cells are going […]
Stem cell journal impact factors: how does your favorite stack up? Read More »
What are stem cell facelifts?Hundreds or even thousands of patients are getting stem cell procedures including right here in the U.S. Many key issues remain unresolved, but clinics and doctors are giving these treatments anyway to make money. Critical issues include lack of proper informed consent, lack of strong data on risks and benefits, huge costs,
Comic on stem cell facelifts Read More »
I recently met the CEO of NeoStem, Dr. Robin Smith, at the 2012 World Stem Cell Summit in Florida. We had a great talk and I invited Dr. Smith to do an interview for my blog. She agreed and has provided very frank answers to my questions, some of which I think were very difficult
Interview with NeoStem CEO Robin Smith Part 1 Read More »
2012 Brazilian Congress on Stem Cells & Cell Therapy, Sao Paulo, Oct 3-6 NYSCF Seventh Annual Translational Stem Cell Research Conference, New York City Oct. 10 – 11 Epigenetics and Stem Cells 2012, Cambridge, UK Oct. 16 – 17, 2012 Texas Cures/ Texans for Stem Cell Research Education Mtg, Austin, Oct. 19 ISSCR-Roddenberry Symposium, Gladstone (San Fran), Oct. 24-25 Houston
2012 stem cell meetings and conferences Read More »
I recently attend a conference in Florida called The World Stem Cell Summit. It was very enjoyable and unique in that it brings together and is open to all constituents of the stem cell world. I gave a couple talks and did an “expert” luncheon at this meeting, but what I enjoyed most was talking
Perfect storm dodged: what are three key challenges for stem cell field going into 2013? Read More »
Here on The Niche I’m giving out a Stem Cell Person of the Year Award for 2012 along with all my other annual awards (e.g. best stem cell journal, paper, blog, comic, activist, etc). 2020 update: you can see future winners of the award here. The Person of the Year winner will get recognition for
Stem Cell Person of the Year Finalists: time to vote Read More »
So far in my series of eight simple reasons not to get an unlicensed stem cell treatment I’ve covered three compelling reasons: potential loss of insurance coverage for negative outcomes that could cost hundreds of thousands of dollars, failure of patient follow up by the doctors and clinics, and exclusion from future clinical trial participation.
Have I got a stem cell for you! We hear a lot about the dangers of an increasing number of rogue stem cell clinics, but another critical trend has flown more under the radar: direct marketing of stem cells to doctors. This is big business and arguably one of the biggest threats to patients. In
Stem cell black market emerging in the U.S. Read More »
This morning here at The World Stem Cell Summit there was a healthy, frank discussion of the risks associated with receiving unlicensed, unproven stem cell therapies. Dr. Jim Guest presented first and gave a great talk about the risks associated with stem cell treatments. One such risk that was mentioned is inadequate characterization of stem
Frank panel on hidden dangers of stem cell treatments to patients at WSCS2012 Read More »
It was near to a stem cell wonk’s heaven to be in the audience for a panel discussion, entitled Understanding the Legal and Policy Challenges to Stem Cell Research, here at the World Stem Cell summit in Florida late this afternoon. The stellar panel included Jeanne Loring of Scripps, Beth Roxland of Hofstra University and formerly of
WSCS2012: outstanding panel discussion on legal challenges to stem cell research Read More »